Retatrutide 20mg (R&D Only)
£100.00
The unique triple-agonist mechanism of Alluvi Retatrutide 20mg, a research-grade peptide available only for use in laboratories, targets the GLP-1, GIP, and glucagon receptors.
£100.00
The unique triple-agonist mechanism of Alluvi Retatrutide 20mg, a research-grade peptide available only for use in laboratories, targets the GLP-1, GIP, and glucagon receptors.
Reviews
There are no reviews yet.